Table 1.
Characteristics of patients with LAPC.
| Characteristics | Cases | % |
|---|---|---|
| Age, years | ||
| <65 | 13 | 59 |
| ≥65 | 9 | 41 |
| Sex | ||
| Male | 6 | 27 |
| Female | 16 | 73 |
| BMI, kg/m2 | ||
| <24 | 18 | 82 |
| ≥24 | 4 | 18 |
| ECOG PS | ||
| 0 | 4 | 18 |
| 1 | 18 | 82 |
| Smoking history | ||
| Yes | 8 | 36 |
| No | 14 | 64 |
| Alcohol | ||
| Yes | 6 | 27 |
| No | 16 | 73 |
| Diabetes | ||
| Yes | 4 | 18 |
| No | 18 | 82 |
| Hypertension | ||
| Yes | 5 | 23 |
| No | 17 | 77 |
| Family history of cancer | ||
| Yes | 3 | 14 |
| No | 19 | 86 |
| Tumor location | ||
| Head & Neck | 11 | 50 |
| Body & Tail | 11 | 50 |
| Tumor size, cm | ||
| <4 | 14 | 64 |
| ≥4 | 8 | 36 |
| CA19-9, U/ml | ||
| <27 | 6 | 27 |
| ≥27 | 16 | 73 |
| Chemotherapy cycles | ||
| <6 | 7 | 32 |
| ≥6 | 15 | 68 |
LAPC, locally advanced pancreatic cancer; BMI, body mass index; ECOG PS, Eastern Cooperative Oncology Group Performance Status; CA 19-9, carbohydrate antigen 19-9.